Updates on Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

被引:0
作者
Haddad, Fadi G. [1 ]
Senapati, Jayastu [1 ]
Short, Nicholas J. [1 ]
Kantarjian, Hagop [1 ]
Jabbour, Elias [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
Tyrosine kinase inhibitor; measurable residual disease; next-generation sequencing; asciminib; olverembatinib; OLVEREMBATINIB;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S62 / S64
页数:3
相关论文
共 50 条
  • [41] Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant
    Haddad, Fadi G.
    Kantarjian, Hagop
    Senapati, Jayastu
    Jain, Nitin
    Short, Nicholas J.
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S79 - S82
  • [42] Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Sugiura, Isamu
    Doki, Noriko
    Hata, Tomoko
    Cho, Ryuko
    Ito, Toshiro
    Suehiro, Youko
    Tanaka, Masatsugu
    Kako, Shinichi
    Matsuda, Mitsuhiro
    Yokoyama, Hisayuki
    Ishikawa, Yuichi
    Taniguchi, Yasuhiro
    Hagihara, Maki
    Ozawa, Yukiyasu
    Ueda, Yasunori
    Hirano, Daiki
    Sakura, Toru
    Tsuji, Masaaki
    Kamae, Tsuyoshi
    Fujita, Hiroyuki
    Hiramoto, Nobuhiro
    Onoda, Masahiro
    Fujisawa, Shin
    Hatta, Yoshihiro
    Dobashi, Nobuaki
    Nishiwaki, Satoshi
    Atsuta, Yoshiko
    Kobayashi, Yukio
    Hayakawa, Fumihiko
    Ohtake, Shigeki
    Naoe, Tomoki
    Miyazaki, Yasushi
    BLOOD ADVANCES, 2022, 6 (02) : 624 - 636
  • [43] Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Kong, Jun
    Zheng, Feng-Mei
    Yan, Chen-Hua
    Wang, Jing-Zhi
    Fu, Hai-Xia
    Wang, Zhi-Dong
    Suo, Pan
    Hu, Guan-Hua
    Lv, Meng
    Chen, Huan
    Mo, Xiao-Dong
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Huang, Xiao-Jun
    Wang, Yu
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 801 - 808
  • [44] Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
    Short, Nicholas J.
    Kantarjian, Hagop
    Jabbour, Elias
    Ravandi, Farhad
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (03) : 193 - 200
  • [45] Management of Philadelphia chromosome positive acute lymphoblastic leukemia in the current era
    Badar, Talha
    Alkhateeb, Hassan
    Aljurf, Mahmoud
    Kharfan-Dabaja, Mohamed A.
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (02)
  • [46] Changing Paradigm of the Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
    Ryuzo Ohno
    Current Hematologic Malignancy Reports, 2010, 5 : 213 - 221
  • [47] Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single- Center Cohort Study
    Tozawa, Nagi
    Yamashita, Takaya
    Nara, Miho
    Fujioka, Yuki
    Ikeda, Sho
    Kobayashi, Takahiro
    Kobayashi, Isuzu
    Kitadate, Akihiro
    Kameoka, Yoshihiro
    Takahashi, Naoto
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [48] A case of ovarian stimulation for fertility preservation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after treatment with dasatinib
    Ogawa, Tatsuyuki
    Ogi, Maki
    Hirata, Shuji
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (03) : 1182 - 1185
  • [49] Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia
    Pavlovsky, Carolina
    Chan, Onyee
    Talati, Chetasi
    Pinilla-Ibarz, Javier
    FUTURE ONCOLOGY, 2019, 15 (03) : 257 - 269
  • [50] Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case-control study
    Cai, Jiaoyang
    Liu, Hu
    Chen, Yumei
    Yu, Jie
    Gao, Ju
    Jiang, Hua
    Zhai, Xiaowen
    Ju, Xiuli
    Wu, Xuedong
    Wang, Ningling
    Tian, Xin
    Liang, Changda
    Fang, Yongjun
    Zhou, Fen
    Li, Hong
    Sun, Lirong
    Yang, Liangchun
    Guo, Jing
    Liu, Aiguo
    Li, Chi-kong
    Zhu, Yiping
    Tang, Jingyan
    Yang, Jun J.
    Shen, Shuhong
    Cheng, Cheng
    Pui, Ching-Hon
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 38